Lack of in vitro cross-reactivity predicts safety of low-molecular weight heparins in heparin-induced thrombocytopenia - Farag, SS; Savoia, H; Omalley, CJ; McGrath, KM (Clinical & Applied Thrombosis-Hemostasis, 1997)